Agilent Nov 24, 2025 Top Wall Street Forecasters Revamp Agilent Expectations Ahead Of Q4 Earnings - Agilent Technologies (NYSE:A) - Benzinga #Agilent Technologies #Wall Street
Agilent Nov 24, 2025 Evelyn Partners Investment Management Services Ltd Reduces Stock Position in Agilent Technologies, Inc. $A - MarketBeat #Agilent Technologies #Partners Investment
Agilent Nov 24, 2025 Handelsbanken Fonder AB Buys 7,524 Shares of Agilent Technologies, Inc. $A - MarketBeat #Agilent Technologies #Handelsbanken Fonder
Thermo Fisher Nov 24, 2025 Thermo Fisher to Purchase Clario to Enhance Clinical Insights and Accelerate Innovation - The Healthcare Technology Report. #Technology Report #Purchase Clario
Agilent Nov 24, 2025 Agilent Technologies Stock (A) Eyeing New Highs Ahead of Earnings – What To Expect - AskTraders.com #Technologies Stock #Highs Ahead
Endpoints News Nov 24, 2025 Biogen pens I&I deal with new Versant macrocycle developer Dayra Therapeutics #Versant Ventures’ #Dayra Therapeutics
Agilent Nov 24, 2025 Agilent Technologies, Inc. $A Shares Sold by Rockefeller Capital Management L.P. - MarketBeat #Agilent Technologies #Shares Sold
Agilent Nov 24, 2025 Legal & General Group Plc Reduces Stake in Agilent Technologies, Inc. $A - MarketBeat #General Group #Agilent Technologies
Agilent Nov 24, 2025 Agilent Technologies, Inc. $A Shares Sold by Mediolanum International Funds Ltd - MarketBeat #Agilent Technologies #Shares Sold
Endpoints News Nov 24, 2025 Bayer’s stock rallies as next-gen blood thinner beats the odds with Phase 3 win #win Bayer #high-profile failures
Endpoints News Nov 24, 2025 Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
BioPharma Dive Nov 24, 2025 Bayer’s experimental blood-thinner notches trial win in stroke prevention #Asundexian Phase #prevention Asundexian
Roche Media Nov 24, 2025 Roche Adopts Veeva Vault CRM and Agentic AI in Global Rollout (NYSE: VEEV) - Stock Titan #Global Rollout #Stock Titan
Roche Media Nov 24, 2025 Veeva Announces Expanded Partnership with Roche - PR Newswire #Announces Expanded #Expanded Partnership
Endpoints News Nov 24, 2025 Craig Crews, Mikael Dolsten raise $32M for Quarry Thera #Mikael Dolsten #Quarry Thera
BioWorld Nov 24, 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed